SCHOTT PHARMA
SCHOTT PHARMA
Aktie · DE000A3ENQ51 · A3ENQ5 (XFRA)
Übersicht
Kein Kurs
Schlusskurs XFRA 22.08.2025: 23,80 EUR
11.09.2025 08:37
1 Tag
-
1 Woche
-
1 Monat
-
3 Monate
-
6 Monate
-
Jahr bis heute
-
1 Jahr
-
2 Jahre
-
3 Jahre
-
4 Jahre
-
5 Jahre
-
10 Jahre
-
20 Jahre
-
Max
-
Aktuelle Kurse von SCHOTT PHARMA
BörseTickerWährungLetzter UmsatzKursTagesveränderung
XETR: XETRA
XETRA
1SXP.F
EUR
11.09.2025 08:37
21,35 EUR
0,10 EUR
+0,47 %
XFRA: Frankfurt
Frankfurt
1SXP.F
EUR
22.08.2025 15:25
23,80 EUR
0,25 EUR
+1,06 %
Firmenprofil zu SCHOTT PHARMA Aktie
SCHOTT Pharma AG & Co. KGaA develops, produces, and sells drug containment solutions and delivery systems for injectable drugs to the pharmaceutical and biotechnology industries worldwide. The company offers polymer and glass syringes, ampoules, vials, and cartridges. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; and SCHOTT TOPPAC unique, a polymer container. The company's cartridge products comprise cartriQ, a pharmaceutical glass cartridge for peptide and protein-based injectables; cartriQ Large Volume, a pharmaceutical glass cartridge for large-volume injectables; Cartridges Double Chamber, a pharmaceutical glass cartridge for lyophilized drugs; Cartridges Break Resistant, a pharmaceutical glass cartridge; and TopLine and StandardLine cartridges. Its vial products include adaptiQ, a pharmaceutical glass vial for injectables; EVERIC pure, a pharmaceutical glass vial for unmatched drug stability; EVERIC care, a pharmaceutical glass vial for a pH range; EVERIC strong & smooth, a pharmaceutical glass vial for the filling line performance; SCHOTT Type I plus, a pharmaceutical glass vial for drug formulations; SCHOTT TopLyo, a pharmaceutical glass vial to avoid fogging for lyophilized drugs; and TopLine and StandardLine vials. Its ampoule products comprise Ampoules easyOPC, a pharmaceutical glass ampoule for ampoule opening; Ampoules Anti-Counterfeiting, a pharmaceutical glass ampoule for protection against drug counterfeiting; and StandardLine ampoules. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.

Unternehmensdaten

Name SCHOTT PHARMA
Firma SCHOTT Pharma AG & Co. KGaA
Website https://www.schott-pharma.com
Heimatbörse XFRA XETRA
WKN A3ENQ5
ISIN DE000A3ENQ51
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Instruments & Supplies
CEO Andreas Reisse
Marktkapitalisierung 4 Mrd.
Land Deutschland
Währung EUR
Mitarbeiter 4,7 T
Adresse Hattenbergstrasse 10, 55122 Mainz
IPO Datum 2023-09-26

Ticker Symbole

Name Symbol
Frankfurt 1SXP.F
XETRA 1SXP.DE
Weitere Aktien
Investoren, die SCHOTT PHARMA halten, haben auch folgende Aktien im Depot:
ARKLE MASTER ISSUER PLC SER 3 CLS B FRN 17/02/52 (REGS)
ARKLE MASTER ISSUER PLC SER 3 CLS B FRN 17/02/52 (REGS) Anleihe
BARCLAYS BANK PLC ZERO CPN SECS 16/01/44
BARCLAYS BANK PLC ZERO CPN SECS 16/01/44 Anleihe
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025